Rosemary Rochford, PhD, Professor of Environmental & Occupational Health and Professor of Microbiology & Immunology, University of Colorado School of Medicine, has been chosen as the 2024 recipient of the prestigious Henle Award from the Board of the International Association for Research on Epstein-Barr virus (EBV) and Associated Diseases.

This award recognizes internationally renowned scientists that have made major contributions to the understanding and/or treatment of EBV and associated diseases.

Spread through bodily fluids, EBV is one of the eight known human herpesviruses, best known for causing infectious mononucleosis. It is also the first human virus discovered to have oncogenic properties and is associated with Burkitt’s lymphoma, nasopharyngeal carcinoma (NPC), gastric carcinoma, Hodgkin’s disease and non-Hodgkin’s lymphoma.

As the Henle award winner, she is invited to deliver a prize lecture at the International Symposium on EBV & KSHV & Related Agents and Diseases – 3rd Joint Meeting in Boston, June 29-July 3, 2024, which will take place on the 60th and 30th anniversaries of the discoveries of EBV and KSHV, respectively, and will be presented with a commemorative plaque.